Heterogeneity of non-alcoholic fatty liver disease: Implications for clinical practice and research activity-Reference-Cited by-同舟云学术

Heterogeneity of non-alcoholic fatty liver disease: Implications for clinical practice and research activity

Published:2021-11-27 Issue:11 Volume:13 Page:1584-1610
ISSN:1948-5182
Container-title:World Journal of Hepatology
language:
Short-container-title:WJH

Author:

Pal Partha,Palui Rajan,Ray Sayantan

Publisher

Baishideng Publishing Group Inc.

Subject

Hepatology

Reference162 articles.

1. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55: 434-438

2. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease

3. Non-alcoholic fatty liver disease: Not time for an obituary just yet!

4. Heterogeneity of non-alcoholic fatty liver disease

5. Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans Is Associated With Nonalcoholic Fatty Liver Disease

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resmetirom's approval: Highlighting the need for comprehensive approaches in NASH therapeutics;Clinics and Research in Hepatology and Gastroenterology;2024-08

2. A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD;Seminars in Liver Disease;2024-07-11

3. Clinical characteristics of lean metabolic-associated fatty liver disease and the impact of concurrent diabetes mellitus;Tzu Chi Medical Journal;2024-07-03

4. Association of NAFLD/NASH, and MAFLD/MASLD with chronic kidney disease: an updated narrative review;Metabolism and Target Organ Damage;2024-04-07

5. The Global Epidemic of Metabolic Fatty Liver Disease;Current Cardiology Reports;2024-02-20